STAND. COM. REP. 44
Honolulu, Hawaii
, 2003
RE: H.B. No. 13
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Second State Legislature
Regular Session of 2003
State of Hawaii
Sir:
Your Committee on Health, to which was referred H.B. No. 13 entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUG COST CONTROL,"
begs leave to report as follows:
The purpose of this bill is to:
(1) Establish a prescription drug cost control educational program aimed at educating physicians and other health care providers authorized to prescribe or dispense prescription drugs about the costs and benefits of various prescription drugs; and
(2) Require pharmaceutical manufacturers doing business in Hawaii to submit annual reports that disclose certain advertising, marketing, and promotional expenditures in the State.
ILWU Local 142 testified in support of this bill. The Hawaii Medical Association and the Pharmaceutical Research and Manufacturers of America opposed the measure. The Office of Information Practices submitted comments.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 13 and recommends that it pass Second Reading and be referred to the Committee on Consumer Protection and Commerce.
Respectfully submitted on behalf of the members of the Committee on Health,
|
____________________________ DENNIS A. ARAKAKI, Chair |
||